标签：lonza 2C-101H

Product Overview

Lonza cord blood CD34+ HLA cells (2C-101H) contain 1 million hematopoietic stem and progenitor cells, and are ideal for studies relating to transplantation and stem cells. They are also widely used in humanized mouse model development. Cord blood derived CD34+ HLA cells (2C-101H) is available with HLA information enabling prescreening and selection of lots most appropriate for your study, providing cost and time savings. HLA information eliminates the need to use cells for obtaining HLA genotype increasing the number of cells that can be used within your experiment. CD34+ HLA cells are ethically sourced and are isolated using Institutional Review Board (IRB) or other regulatory authority-approved consent forms and protocols. Large inventory supports stable supply from a single vendor.

Lonza 脐血 CD34+ HLA 细胞 (2C-101H) 含有 100 万个造血干细胞和祖细胞，是移植和干细胞相关研究的理想选择。 它们还广泛用于人源化小鼠模型的开发。 脐带血来源的 CD34+ HLA 细胞 (2C-101H) 可提供 HLA 信息，从而能够预筛选和选择最适合您的研究的批次，从而节省成本和时间。 HLA 信息消除了使用细胞获取 HLA 基因型的需要，从而增加了可在您的实验中使用的细胞数量。 CD34+ HLA 细胞的来源符合伦理，并使用机构审查委员会 (IRB) 或其他监管机构批准的同意书和协议进行分离。 大库存支持单一供应商的稳定供应。

Guarantee

Lonza guarantees the performance of Cells only if appropriate Lonza recommended Media and Reagents are used exclusively and the recommended storage and use protocols are followed. Any modifications made to the recommended cell systems including the use of alternative media, reagents or protocols, will void cell and media performance guarantees.

只有在专门使用适当的 Lonza 推荐的培养基和试剂并遵循推荐的储存和使用协议时，Lonza 才能保证细胞的性能。 对推荐的细胞系统进行的任何修改，包括使用替代培养基、试剂或方案，都将使细胞和培养基性能保证失效。